Search

Call the Presidential candidates to account for science and make sure they recognise scientific issues are global, says world-leading biologist and Nobel laureate David Baltimore.

Thin drug pipelines prompted the biopharmaceuticals licensing splurge of 2006/7. Now pharma and large biotechs are looking to tap into university research too.

Nuclear power is back in favour – but does Europe have the skills and resources to bring the industry into the 21st century?

The move from the warm embrace of global healthcare giant GE to a tiny biotech start-up was an exhilarating experience for Bill Clarke.

The European Commission wants member states to adopt a code of conduct for nanotechnology research at universities, research institutes and companies.

Ten European research institutions and a UK biotech company are joining forces to study the memory loss in Alzheimer’s and to develop treatments.